Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Immuneering Corporation (Nasdaq: IMRX) will present at the 35th Annual Piper Sandler Healthcare Conference to discuss the company’s pipeline, platform, and business strategy. The presentation will feature key executives and will be webcast live and archived on the company's website.

CAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop medicines for broad populations of cancer patients with an initial aim to develop a universal-RAS therapy, today announced that management will present at the 35^th Annual Piper Sandler Healthcare Conference to discuss the company’s pipeline, platform, and business strategy. Participating will be Ben Zeskind, Ph.D., Co-Founder and Chief Executive Officer, Brett Hall, Ph.D., Chief Scientific Officer, Harold “E.B.” Brakewood, Chief Business Officer, and Mallory Morales, CPA, Chief Accounting Officer, Treasurer.

Format: Fireside chat and 1x1 Investor Meetings
Presentation: November 30, 2023 from 11:30 – 11:55 am ET

The presentations will be webcast live and archived in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.

About Immuneering Corporation

Immuneering is a clinical-stage oncology company seeking to develop medicines for broad populations of cancer patients with an initial aim to develop a universal-RAS therapy. The Company aims to achieve universal activity through deep cyclic inhibition of the MAPK pathway, impacting cancer cells while sparing healthy cells. Immuneering’s lead product candidate, IMM-1-104, is in a Phase 1/2a study in patients with advanced solid tumors harboring RAS mutations. The company’s development pipeline also includes IMM-6-415, a universal-MAPK program, as well as several early-stage programs. For more information, please visit www.immuneering.com.

Media Contact:
Gina Nugent 
Nugent Communications 
617-460-3579 
gina@nugentcommunications.com 

Investor Contacts: 
Laurence Watts 
Gilmartin Group 
619-916-7620 
laurence@gilmartinir.com 

or

Kiki Patel, PharmD 
Gilmartin Group 
332-895-3225
kiki@gilmartinir.com 

FAQ

What is Immuneering Corporation presenting at the 35th Annual Piper Sandler Healthcare Conference?

Immuneering Corporation will present to discuss the company’s pipeline, platform, and business strategy.

When will the presentation take place?

The presentation will take place on November 30, 2023, from 11:30 – 11:55 am ET.

Where can I watch the live webcast and find the archived presentation?

The live webcast and archived presentation will be available in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.